mutations supplied The point that, as stated underneath, CLL therapy is based around the presence or absence of those mutations. The current consensus is the fact that, in addition to clonal mutations, subclonal mutations by using a variant allelic frequency ranging from 5 to 10% (and thus beneath the edge of detection by regular molecular procedur